ROVALPITUZUMAB

UNII:	44AD2077P0
Formula:
Preferred Substance Name:	ROVALPITUZUMAB

1613313-01-1
IMMUNOGLOBULIN G1, ANTI-(PROTEIN DLL3 (DELTA-LIKE LIGAND 3)) (HUMAN-MUS MUSCULUS MONOCLONAL SC0001 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SC0001 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN DELTA-LIKE PROTEIN 3 (DROSOPHILA DELTA HOMOLOG 3, DELTA 3)) HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.1 HEAVY CHAIN (1-447) (HUMANIZED VH (HOMO SAPIENS IGHV1-18*1 (87%) (IGHD)-IGHJ4*01) (8.8.11) (1-118) -HOMO SAPIENS IGHG1*01 (CH3 K107>DEL(448)) (119-447)), (221-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV3-15*01 (87%) IGKJ2*02) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')), DIMER (227-227'':230-230'')-BISDISULFIDE
ROVALPITUZUMAB [INN]
ROVALPITUZUMAB [USAN]
SC0001
SC-0001

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ROVALPITUZUMAB

Synonyms and Mappings

Resources